Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


Pneumonia Testing Market in Asia Pacific is expected to register a CAGR of 11.2% during the forecast period (2020-2026)

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Asia Pacific Pneumonia Testing Market, published by KBV research, the Asia Pacific Pneumonia Testing Market would witness market growth of 11.2% CAGR during the forecast period (2020-2026).

The China market dominated the Asia Pacific Consumables Pneumonia Testing Market by Country 2019, growing at a CAGR of 10.9 % during the forecast period. The Japan market is experiencing a CAGR of 12.3% during (2020 - 2026). Additionally, The India market is anticipated to grow at a CAGR of 13.6% during (2020 - 2026).

The Enzyme-Linked Immunosorbent Assay (ELISA) market dominated the South Korea Pneumonia Testing Market by Technology 2019, growing at a CAGR of 11 % during the forecast period. The Immunofluorescence market is witnessing a CAGR of 13.8% during (2020 - 2026). The Western Blot market is estimated to grow at a CAGR of 11.8% during (2020 - 2026). Additionally, The Immunohistochemistry (IHC) market is expected to witness highest CAGR of 15.8% during (2020 - 2026).

The Point-Of-Care (POC) Testing market dominated the Malaysia Pneumonia Testing Market by Method 2019thereby, achieving a market value of $17.1 million by 2026. The Immunodiagnostics market is showcasing a CAGR of 15% during (2020 - 2026). Additionally, The Molecular Diagnostics market would exhibit highest CAGR of 17.5% during (2020 - 2026).

Full Report: https://www.kbvresearch.com/asia-pacific-pneumonia-testing-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Becton, Dickinson and Company, bioMérieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Hologic, Inc., Meridian Bioscience Inc., Quest Diagnostics Incorporated, Quidel Corporation and Thermo Fisher Scientific.

Asia Pacific Pneumonia Testing Market Segmentation

By Method

  • Point-Of-Care (POC) Testing
  • Immunodiagnostics
  • Molecular Diagnostics

By End User

  • Diagnostic Centers
  • Hospitals
  • Homecare
  • Others

By Type

  • Analyzers
  • Consumables

By Technology

  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunofluorescence
  • Western Blot,
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • Other Technology.

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • bioMérieux
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Meridian Bioscience Inc.
  • Quest Diagnostics Incorporated
  • Quidel Corporation
  • Thermo Fisher Scientific

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Pneumonia Testing Market

North America Pneumonia Testing Market

Europe Pneumonia Testing Market

LAMEA Pneumonia Testing Market



SUBSCRIPTION MODEL